MOTCO’s Regeneron Pharmaceuticals REGN Stock Holding History

MOTCO’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.87K	Buy	3 +2	+200%	+$1.36K	﹤0.01%	539
2026 Q1	$773	Hold	1	–	–	﹤0.01%	568
2025 Q4	$772	Hold	1	–	–	﹤0.01%	597
2025 Q3	$562	Hold	1	–	–	﹤0.01%	621
2025 Q2	$545	Hold	1	–	–	﹤0.01%	589
2025 Q1	$634	Buy	+1	New	+$688	﹤0.01%	571
2024 Q1	–	Sell	-10	Closed	-$8.78K	–	763
2023 Q4	$8.78K	Hold	10	–	–	﹤0.01%	489
2023 Q3	$8.23K	Hold	10	–	–	﹤0.01%	521
2023 Q2	$7.18K	Buy	+10	New	+$7.71K	﹤0.01%	527
2021 Q1	–	Sell	-5	Closed	-$2K	–	761
2020 Q4	$2K	Hold	5	–	–	﹤0.01%	694
2020 Q3	$3K	Hold	5	–	–	﹤0.01%	560
2020 Q2	$3K	Hold	5	–	–	﹤0.01%	518
2020 Q1	$2K	Buy	+5	New	+$2.06K	﹤0.01%	557
2019 Q3	–	Sell	-16	Closed	-$5K	–	694
2019 Q2	$5K	Buy	+16	New	+$5.33K	﹤0.01%	720
2016 Q4	–	Sell	-19	Closed	-$8K	–	630
2016 Q3	$8K	Buy	+19	New	+$7.62K	﹤0.01%	498

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MOTCO's REGN Position: Q2 2026 in Review

MOTCO increased its Regeneron Pharmaceuticals (REGN) stake by 200% in Q2 2026, buying an estimated $1.36K and bringing the position to 3 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

MOTCO first reported a position in REGN in Q3 2016 and has held it in 15 quarters since. The position peaked at $8.78K in Q4 2023. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

MOTCO held 3 shares of Regeneron Pharmaceuticals worth $1.87K as of Q2 2026.
MOTCO bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
Regeneron Pharmaceuticals made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #539 holding.
MOTCO first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
MOTCO's Regeneron Pharmaceuticals position peaked at $8.78K in Q4 2023.
1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.